Andrea Duminuco

651 total citations
60 papers, 344 citations indexed

About

Andrea Duminuco is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Andrea Duminuco has authored 60 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 32 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Andrea Duminuco's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Acute Myeloid Leukemia Research (16 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Andrea Duminuco is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Acute Myeloid Leukemia Research (16 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Andrea Duminuco collaborates with scholars based in Italy, United Kingdom and United States. Andrea Duminuco's co-authors include Giuseppe A. Palumbo, Francesco Di Raimondo, Cesarina Giallongo, Calogero Vetro, Salvatore Leotta, Daniele Tibullo, Claire Harrison, Alessandra Romano, Giuseppe Milone and Alessandra Cupri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrea Duminuco

54 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Duminuco Italy 11 142 128 78 42 32 60 344
Phillip L.R. Nicolson United Kingdom 12 87 0.6× 215 1.7× 42 0.5× 40 1.0× 74 2.3× 32 368
Ming‐Chih Chang Taiwan 11 147 1.0× 151 1.2× 97 1.2× 91 2.2× 57 1.8× 31 373
Eva Leinøe Denmark 10 81 0.6× 232 1.8× 34 0.4× 19 0.5× 36 1.1× 31 338
Gianna Maria D’Elia Italy 13 116 0.8× 159 1.2× 42 0.5× 128 3.0× 37 1.2× 33 357
Ambra Di Veroli Italy 13 118 0.8× 228 1.8× 86 1.1× 40 1.0× 14 0.4× 31 340
Tamara Everington United Kingdom 10 240 1.7× 192 1.5× 174 2.2× 46 1.1× 13 0.4× 23 502
Omar Racchi Italy 11 100 0.7× 123 1.0× 73 0.9× 105 2.5× 76 2.4× 19 463
Angela Rago Italy 10 136 1.0× 179 1.4× 72 0.9× 67 1.6× 44 1.4× 29 334
Beverly A. Schaefer United States 9 121 0.9× 137 1.1× 30 0.4× 57 1.4× 19 0.6× 19 284
Ümran Çalışkan Türkiye 11 55 0.4× 99 0.8× 46 0.6× 25 0.6× 57 1.8× 42 292

Countries citing papers authored by Andrea Duminuco

Since Specialization
Citations

This map shows the geographic impact of Andrea Duminuco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Duminuco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Duminuco more than expected).

Fields of papers citing papers by Andrea Duminuco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Duminuco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Duminuco. The network helps show where Andrea Duminuco may publish in the future.

Co-authorship network of co-authors of Andrea Duminuco

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Duminuco. A scholar is included among the top collaborators of Andrea Duminuco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Duminuco. Andrea Duminuco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olimpieri, Pier Paolo, Gaetano Giuffrida, Edoardo Milanetti, et al.. (2025). Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database. Hematology Reports. 17(5). 54–54.
2.
Duminuco, Andrea, Patrick Harrington, Vittorio Del Fabro, et al.. (2025). Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape. Pharmaceuticals. 18(8). 1212–1212. 1 indexed citations
3.
Duminuco, Andrea, Natalia Curto‐García, Priya Sriskandarajah, et al.. (2025). QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms. Leukemia. 39(10). 2384–2390. 4 indexed citations
4.
Duminuco, Andrea, Salvatore Leotta, Elisa Mauro, et al.. (2025). Real-World Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric Cohort. Journal of Clinical Medicine. 14(14). 5110–5110. 1 indexed citations
5.
Duminuco, Andrea, Laura Longo, Serena Brancati, et al.. (2025). Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax. Journal of Clinical Medicine. 14(14). 5007–5007. 2 indexed citations
6.
Vetro, Calogero, et al.. (2025). Benign purpuric cutaneous eruption in a young patient with AML treated with CPX-351. Leukemia & lymphoma. 67(1). 218–219.
7.
Chifotides, Helen T., Andrea Duminuco, Elena Torre, et al.. (2025). Emerging Therapeutic Approaches for Anemia in Myelofibrosis. Current Hematologic Malignancy Reports. 20(1). 7–7. 1 indexed citations
8.
Duminuco, Andrea, Annalisa Chiarenza, Giovanna Motta, et al.. (2024). Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma. Cancers. 16(4). 826–826. 1 indexed citations
9.
Kuykendall, Andrew, Somedeb Ball, Barbara Mora, et al.. (2024). Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib. JCO Precision Oncology. 8(8). e2300593–e2300593. 3 indexed citations
10.
Gozzo, Lucia, Salvatore Leotta, Giovanni Luca Romano, et al.. (2024). Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease. Journal of Clinical Medicine. 13(14). 4273–4273. 2 indexed citations
11.
Duminuco, Andrea, Joshua Au Yeung, Natalia Curto‐García, et al.. (2024). Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms. HemaSphere. 8(8). e143–e143. 7 indexed citations
12.
Spina, Enrico La, Sebastiano Giallongo, Cesarina Giallongo, et al.. (2023). Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases. Frontiers in Oncology. 13. 1141610–1141610. 4 indexed citations
13.
Duminuco, Andrea, Alessandra Romano, Enrico La Spina, et al.. (2023). Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab. Frontiers in Oncology. 13. 1157610–1157610. 8 indexed citations
14.
Vetro, Calogero, Uroš Markovic, Andrea Duminuco, et al.. (2023). A case of high‐risk AML in a patient with advanced systemic mastocytosis. SHILAP Revista de lepidopterología. 11(7). e7134–e7134. 4 indexed citations
15.
Fabro, Vittorio Del, Andrea Duminuco, Uroš Markovic, et al.. (2023). Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study. Cancers. 15(16). 4036–4036. 3 indexed citations
16.
Duminuco, Andrea, et al.. (2023). AIPSS‐MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib. Cancer Reports. 6(10). e1881–e1881. 3 indexed citations
17.
Duminuco, Andrea, Giuliana Giunta, Concetta Conticello, et al.. (2023). Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions. Cancer. 130(1). 41–50. 13 indexed citations
18.
Gozzo, Lucia, Serena Brancati, Andrea Duminuco, et al.. (2023). Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data. Healthcare. 11(10). 1479–1479. 8 indexed citations
19.
Pennisi, Maria Stella, Sandra Di Gregorio, Elena Tirrò, et al.. (2023). Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports. SHILAP Revista de lepidopterología. 15(2). 317–324. 1 indexed citations
20.
Duminuco, Andrea, et al.. (2022). Regression of leukemia cutis with gilteritinib in a case of FLT3-positive acute myeloid leukemia. SHILAP Revista de lepidopterología. 7. 100184–100184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip L.R. Nicolson Breakdown of academic impact, for papers by Ming‐Chih Chang Breakdown of academic impact, for papers by Eva Leinøe Breakdown of academic impact, for papers by Gianna Maria D’Elia Breakdown of academic impact, for papers by Ambra Di Veroli Breakdown of academic impact, for papers by Tamara Everington Breakdown of academic impact, for papers by Omar Racchi Breakdown of academic impact, for papers by Angela Rago Breakdown of academic impact, for papers by Beverly A. Schaefer Breakdown of academic impact, for papers by Ümran Çalışkan
Rankless by CCL
2026